Published in Arch Ophthalmol on February 01, 2003
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care (2009) 26.77
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol (2013) 3.33
Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19
Obesity and eye diseases. Surv Ophthalmol (2007) 2.13
Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care (2008) 2.09
Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care (2010) 1.95
The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2006) 1.51
Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. Am J Ophthalmol (2007) 1.39
Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol (2009) 1.34
PPARalpha: an emerging therapeutic target in diabetic microvascular damage. Nat Rev Endocrinol (2010) 1.34
Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med (2011) 1.30
Imaging of the parafoveal capillary network and its integrity analysis using fractal dimension. Biomed Opt Express (2011) 1.26
Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care (2008) 1.17
Prevalence and determinants of diabetic retinopathy in Al hasa region of saudi arabia: primary health care centre based cross-sectional survey, 2007-2009. Middle East Afr J Ophthalmol (2010) 1.12
Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands. Diabetes Care (2011) 1.07
Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol (2011) 1.05
New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes (2012) 1.01
Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation. Diabetol Metab Syndr (2009) 1.00
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia (2013) 0.98
Association of ideal cardiovascular health metrics and retinal microvascular findings: the Atherosclerosis Risk in Communities Study. J Am Heart Assoc (2013) 0.95
Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. Int J Ophthalmol (2011) 0.92
Prevalence and associated factors of diabetic retinopathy in rural Korea: the Chungju metabolic disease cohort study. J Korean Med Sci (2011) 0.92
Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit. Antioxid Redox Signal (2014) 0.92
Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease. J Res Med Sci (2011) 0.90
Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study. Ophthalmology (2011) 0.90
Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes. Oxid Med Cell Longev (2010) 0.89
Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm (2013) 0.89
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes (2013) 0.88
Ocular associations of metabolic syndrome. Indian J Endocrinol Metab (2012) 0.86
Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm (2013) 0.85
Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? Br J Ophthalmol (2006) 0.84
HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc Diabetol (2013) 0.84
Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men. Sci Rep (2014) 0.84
Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One (2013) 0.83
P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans. Am J Ophthalmol (2015) 0.83
Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community. Diabetes Metab J (2012) 0.81
Use of glycosylated haemoglobin as diagnostic tool in Greenland: prevalence of diagnosed diabetes mellitus. Diabetol Metab Syndr (2013) 0.80
Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study. Clin Ophthalmol (2007) 0.80
Ocular and systemic causes of retinopathy in patients without diabetes mellitus. BMJ (2004) 0.78
Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp Diabetes Res (2012) 0.78
Longitudinal validation of hemoglobin A(1c) criteria for diabetes diagnosis: risk of retinopathy. Diabetes (2012) 0.77
Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus. J Diabetes Sci Technol (2009) 0.77
Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia. J Family Community Med (2016) 0.77
Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction. Clin Ophthalmol (2010) 0.76
The optimal cutoff value of glycated hemoglobin for detection of diabetic retinopathy. Diabetes Metab J (2015) 0.75
Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration. J Diabetes Res (2016) 0.75
Body mass index and retinopathy in type 1 diabetic patients. Int J Endocrinol (2014) 0.75
Evidence for current diagnostic criteria of diabetes mellitus. World J Diabetes (2016) 0.75
Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol (2016) 0.75
High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome. PLoS One (2016) 0.75
Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population. Iran Red Crescent Med J (2016) 0.75
The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012. PLoS One (2016) 0.75
The Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese Population. J Diabetes Res (2016) 0.75
Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study. Int J Clin Exp Med (2015) 0.75
The association between urinary lgM excretion and diabetic retinopathy in diabetic patients. J Diabetes Metab Disord (2016) 0.75
Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes? Curr Diab Rep (2017) 0.75
Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol (2006) 20.17
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Translating the A1C assay into estimated average glucose values. Diabetes Care (2008) 11.55
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2006) 9.87
How to measure comorbidity. a critical review of available methods. J Clin Epidemiol (2003) 9.58
Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care (2005) 8.94
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 8.27
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial. JAMA (2002) 7.31
Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) (2008) 6.88
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol (2010) 6.61
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res (2010) 6.09
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol (2009) 6.00
When to use agreement versus reliability measures. J Clin Epidemiol (2006) 5.24
Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet (2002) 4.39
Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol (2002) 4.19
The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol (2010) 4.10
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67
Episodes of low back pain: a proposal for uniform definitions to be used in research. Spine (Phila Pa 1976) (2002) 3.63
Prevention of hip fractures by external hip protectors: a randomized controlled trial. JAMA (2003) 3.46
Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab (2005) 3.36
Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med (2009) 3.29
Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res (2011) 3.27
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med (2004) 3.26
Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care (2005) 3.19
Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) (2005) 3.13
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst (2008) 3.13
Manual therapy, physical therapy, or continued care by a general practitioner for patients with neck pain. A randomized, controlled trial. Ann Intern Med (2002) 3.13
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev (2006) 3.06
Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis. BMJ (2008) 3.05
Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care (2004) 3.03
Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis (2006) 2.95
A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) (2008) 2.94
Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes (2006) 2.88
Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis. Spine J (2004) 2.87
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care (2009) 2.75
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One (2007) 2.70
Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol (2006) 2.66
Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation (2005) 2.66
Occupational therapy for stroke patients: a systematic review. Stroke (2003) 2.62
Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care (2007) 2.61
Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev (2010) 2.57
The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol (2004) 2.56
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum (2009) 2.55
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ (2010) 2.54
Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med (2007) 2.54
A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care (2002) 2.51
Multifactorial intervention to reduce falls in older people at high risk of recurrent falls: a randomized controlled trial. Arch Intern Med (2010) 2.34
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28
Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med (2007) 2.26
Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care (2005) 2.25
"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet (2005) 2.24
Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care (2004) 2.24
[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]. Ned Tijdschr Geneeskd (2012) 2.23
Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain. Cochrane Database Syst Rev (2010) 2.21
Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother (2005) 2.18
Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int (2002) 2.18